{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:14:07Z","timestamp":1793834047417,"version":"4.6.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cpcardiol.2023.102052","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T11:00:58Z","timestamp":1693047658000},"page":"102052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"PA","title":["Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-8355","authenticated-orcid":false,"given":"Ashot","family":"Avagimyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fogacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Pogosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Kakrurskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Urazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Kobalava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Mikhaleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rositsa","family":"Vandysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioeva","family":"Zarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Trofimenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grizelda","family":"Navasardyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Mkrtchyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinaida","family":"Jndoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anait","family":"Aznauryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karmen","family":"Saahakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Di","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.102052_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"6S","key":"10.1016\/j.cpcardiol.2023.102052_bib0002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2017.04.010","article-title":"Diabetes mellitus and heart failure","volume":"130","author":"Lehrke","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0003","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-020-0798-y","article-title":"Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities","volume":"115","author":"Cuijpers","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0005","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4093\/dmj.2020.0282","article-title":"Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0007","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4093\/dmj.2021.0239","article-title":"Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0008","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0009","doi-asserted-by":"crossref","first-page":"e14616","DOI":"10.1111\/dme.14616","article-title":"Cohort profile: National Diabetes Audit forEngland and Wales","volume":"38","author":"Holman","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0010","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ejhf.2400","volume":"24","author":"Omerovic","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0012","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41569-019-0202-5","article-title":"70-year legacy of the Framingham Heart Study","volume":"16","author":"Andersson","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0014","article-title":"The pathophysiological basis of diabetic cardiomyopathy development","volume":"47","author":"Avagimyan","year":"2022","journal-title":"CurrProblCardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0015","first-page":"99","article-title":"The molecular mechanism of diabetes mellitus - related impairment of cardiovascular homeostasis (review)","volume":"315","author":"Avagimyan","year":"2021","journal-title":"Georgian Med News"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0016","article-title":"Diabefit as a modifier of fructose-induced impairment of cardio-vascular system","volume":"47","author":"Avagimyan","year":"2022","journal-title":"CurrProblCardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0017","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc16-0024","article-title":"Persistent effects of intensive glycemic control on retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) follow-on study","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0018","doi-asserted-by":"crossref","first-page":"e14639","DOI":"10.1111\/dme.14639","article-title":"Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study","volume":"38","author":"Ligthart","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0019","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2183\/pjab.95.039","article-title":"Structure and function of the insulin receptor-a personal perspective","volume":"95","author":"Kasuga","year":"2019","journal-title":"Proc JpnAcadSer B Phys Biol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0021","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0022","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fphar.2019.00998","article-title":"Carvacrol attenuates diabetic cardiomyopathy by modulating the PI3K\/AKT\/GLUT4 pathway in diabetic mice","volume":"10","author":"Hou","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102052_bib0023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10741-021-10200-y","article-title":"Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants","volume":"28","author":"Prandi","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0024","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.18087\/cardio.2017.12.10063","article-title":"Gender specific characteristics of ventricular-atrial remodeling in recurrent atrial fibrillation in ischemic heart disease patients with arterial hypertension","volume":"57","author":"Kobalava","year":"2017","journal-title":"Kardiologiia"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.20996\/1819-6446-2017-13-4-541-549","article-title":"Atrial fibrillation and arterial hypertension: gender differences of ventricu- loatrial remodeling with preserved ejection fraction","volume":"13","author":"Kobalava","year":"2017","journal-title":"Ration Pharmacother Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105835","article-title":"Hyperkalemia with RAAS inhibition: mechanism, clinical significance, and management","volume":"172","author":"Hundemer","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107880","article-title":"Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease","volume":"35","author":"Ambinathan","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0029","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: implications for diabetes","volume":"302","author":"Olivares-Reyes","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0030","first-page":"53","article-title":"Aldosterone and type 2 diabetes mellitus","volume":"26","author":"Zavatta","year":"2016","journal-title":"HormMolBiolClinInvestig"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac hypertrophy: an introduction to molecular and cellular basis","volume":"22","author":"Samak","year":"2016","journal-title":"Med SciMonit Basic Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0033","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0034","doi-asserted-by":"crossref","first-page":"H92","DOI":"10.1152\/ajpheart.00719.2017","article-title":"Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis","volume":"315","author":"McDonald","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0035","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death","volume":"143","author":"Umapathi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0036","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.117.031942","article-title":"O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure","volume":"140","author":"Mariya","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0037","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0038","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.3390\/ijms21176421","article-title":"Oxidative stress, kinase activity and inflammatory implications in right ventricular hypertrophy and heart failure under hypobaric hypoxia","volume":"21","author":"Pena","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.690341","article-title":"Oxidative stress, kinase activation, and inflammatory pathways involved in effects on smooth muscle cells during pulmonary artery hypertension under hypobaric hypoxia exposure","volume":"12","author":"Siques","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvq239","article-title":"Mitochondria in the diabetic heart","volume":"88","author":"Bugger","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0041","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5534\/wjmh.210146","article-title":"The role of mitochondrial dynamic dysfunction in age-associated Type 2 diabetes","volume":"40","author":"Vezza","year":"2022","journal-title":"World J Mens Health"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0042","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10456-022-09835-8","article-title":"Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance","volume":"25","author":"Sun","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0043","first-page":"741","article-title":"Mitochondrial creatine kinase attenuates pathologic remodeling in heart failure","volume":"130","author":"Keceli","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0044","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1023\/A:1012428812780","article-title":"Mitochondrial creatine kinase: properties and function","volume":"66","author":"Lipskaya","year":"2001","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000046878","article-title":"Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage","volume":"10","author":"Dolder","year":"2001","journal-title":"Biol Signals Recept"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0046","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0047","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.3390\/ijms221910579","article-title":"Metabolic remodeling and implicated calcium and signal transduction pathways in the pathogenesis of heart failure","volume":"22","author":"Chaanine","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0048","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0049","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2009.11.026","article-title":"Coronary artery calcium and cardiovascular risk in diabetes","volume":"210","author":"Elkeles","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/dc20-0166","article-title":"Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium","volume":"43","author":"Wong","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117908","article-title":"Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-\u03baB\/Nrf-2\/PPAR-\u03b3 interplay in mice","volume":"256","author":"Abdelhamid","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0052","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/s41467-020-19205-x","article-title":"Intellectual disability-associated factor Zbtb11 cooperates with NRF-2\/GABP to control mitochondrial function","volume":"11","author":"Wilson","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0053","article-title":"Hyperglycemia and endothelial dysfunction in atherosclerosis","volume":"2012","author":"Funk","year":"2012","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0054","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12265-012-9387-2","article-title":"Oxidative stress, Nox isoforms and complications of diabetes\u2013potential targets for novel therapies","volume":"5","author":"Sedeek","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/toxins10100404","article-title":"Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions","volume":"10","author":"Maciel","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0056","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/ATVBAHA.111.226340","article-title":"Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-\u03b1: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species","volume":"31","author":"World","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0057","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0058","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0059","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0060","article-title":"Endothelial dysfunction and diabetic cardiomyopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0061","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.34067\/KID.0002772021","article-title":"SGLT2 inhibitors: physiology and pharmacology","volume":"2","author":"Wright","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0062","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11886-021-01486-3","article-title":"SGLT-2 inhibitors in heart failure: guide for prescribing and future perspectives","volume":"23","author":"Garla","year":"2021","journal-title":"CurrCardiol Rep"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0063","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/1568026619666190828161409","article-title":"Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction","volume":"19","author":"Liu","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0064","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","article-title":"Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0066","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","article-title":"Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases","volume":"18","author":"Ren","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0067","doi-asserted-by":"crossref","first-page":"e05033","DOI":"10.7554\/eLife.05033","article-title":"The small molecule ISRIB reverses the effects of eIF2\u03b1 phosphorylation on translation and stress granule assembly","volume":"4","author":"Sidrauski","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0068","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/ajpheart.00362.2016","article-title":"Endoplasmic reticulum stress increases brain MAPK signaling, inflammation and renin-angiotensin system activity and sympathetic nerve activity in heart failure","volume":"311","author":"Wei","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0069","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6569728","article-title":"Hyperglycemia induces endoplasmic reticulum stress in atrial cardiomyocytes, and Mitofusin-2 downregulation prevents mitochondrial dysfunction and subsequent cell death","volume":"2020","author":"Yuan","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0070","article-title":"Endoplasmic reticulum stress-mediated mitochondrial dysfunction in aged hearts","volume":"1866","author":"Chen","year":"2020","journal-title":"BiochimBiophysActaMol Basis Dis"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0071","doi-asserted-by":"crossref","first-page":"e13453","DOI":"10.1111\/acel.13453","article-title":"Chronic low-grade inflammation in heart failure with preserved ejection fraction","volume":"20","author":"Mesquita","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0072","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0073","first-page":"27","article-title":"Role of Inflammation in Heart Failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"CurrAtheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0074","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring HarbPerspect Biol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jpi.12418","article-title":"Melatonin protects against diabetic cardiomyopathy through Mst1\/Sirt3 signaling","volume":"63","author":"Zhang","year":"2017","journal-title":"J Pineal Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0076","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0077","first-page":"30","article-title":"TLR signalling and association of TLR polymorphism with cardiovascular diseases","volume":"87","author":"Sharma","year":"2016","journal-title":"VasculPharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0078","doi-asserted-by":"crossref","first-page":"14482","DOI":"10.18632\/aging.103640","article-title":"Sirt1 improves heart failure through modulating the NF-\u03baB p65\/microRNA-155\/BNDF signaling cascade","volume":"13","author":"Lin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0079","first-page":"150","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"CardiovascDiabetol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0080","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0081","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"issue":"Suppl. 4","key":"10.1016\/j.cpcardiol.2023.102052_bib0082","first-page":"19","article-title":"The role of interleukin 1 in the development of human diseases","volume":"56","author":"Nasonov","year":"2018","journal-title":"Nauchno-PrakticheskayaRevmatologiya\u202f=\u202fRheumatol Sci Pract"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0083","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cardfail.2014.11.004","article-title":"Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis","volume":"21","author":"Glezeva","year":"2015","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0084","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14341\/omet201545-13","article-title":"Perivascular adipose tissue: role in the pathogenesis of obesity, type 2 diabetes mellitus and cardiovascular pathology","volume":"12","author":"Romantsova","year":"2015","journal-title":"Obesity Metabol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0085","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.15829\/1560-4071-2021-4567","article-title":"Perivascular adipose tissue in the pathogenesis of cardiovascular disease","volume":"26","author":"Kim","year":"2021","journal-title":"Rus J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0086","doi-asserted-by":"crossref","first-page":"633","DOI":"10.15789\/1563-0625-2019-4-633-642","article-title":"Role of perivascular adipose tissue in the development of atherosclerotic and nonatherosclerotic diseases","volume":"21","author":"Uchasova","year":"2019","journal-title":"Medical Immunology (Russia)"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0087","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14341\/probl200955640-45","article-title":"Inflammation of adipose tissue. Part 3. Pathogenetic role in the development of atherosclerosis","volume":"55","author":"Shvarts","year":"2009","journal-title":"Probl Endocrinol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0088","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002480","article-title":"Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis","volume":"9","author":"Chowdhury","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-018-0554-0","article-title":"Nutritional ketosis delays the onset of isoflurane induced anesthesia","volume":"18","author":"Ari","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/jpgm.JPGM_16_17","article-title":"Ketogenic diet in endocrine disorders: current perspectives","volume":"63","author":"Gupta","year":"2017","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0091","first-page":"233","article-title":"Low carb diet - to love or to hate?","volume":"25","author":"Sima","year":"2018","journal-title":"Rom J Diabetes Nutr Metab Dis"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0092","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","article-title":"Implications of altered ketone metabolism and therapeutic ketosis in heart failure","volume":"141","author":"Selvaraj","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102052_bib0093","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.865489","article-title":"Low carbohydrate diets for diabetic cardiomyopathy: a hypothesis","volume":"9","author":"Kleissl-Muir","year":"2022","journal-title":"Front Nutr"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623004693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623004693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:23:43Z","timestamp":1758939823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623004693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0146280623004693"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102052","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"102052"}}